Your browser doesn't support javascript.
loading
Polygenic association between attention-deficit/hyperactivity disorder liability and cognitive impairments.
Vainieri, Isabella; Martin, Joanna; Rommel, Anna-Sophie; Asherson, Philip; Banaschewski, Tobias; Buitelaar, Jan; Cormand, Bru; Crosbie, Jennifer; Faraone, Stephen V; Franke, Barbara; Loo, Sandra K; Miranda, Ana; Manor, Iris; Oades, Robert D; Purves, Kirstin L; Ramos-Quiroga, J Antoni; Ribasés, Marta; Roeyers, Herbert; Rothenberger, Aribert; Schachar, Russell; Sergeant, Joseph; Steinhausen, Hans-Christoph; Vuijk, Pieter J; Doyle, Alysa E; Kuntsi, Jonna.
  • Vainieri I; Social, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.
  • Martin J; MRC Centre for Neuropsychiatric Genetics & Genomics, School of Medicine, Cardiff University, Cardiff, UK.
  • Rommel AS; Department of Psychiatry & Department of Environmental Medicine, Public Health at the Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Asherson P; Social, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.
  • Banaschewski T; Department of Child and Adolescent Psychiatry, Central Institute of Mental Health and Mannheim Medical Faculty, University of Heidelberg, Heidelberg, Germany.
  • Buitelaar J; Karakter Child and Adolescent Psychiatry University Center, Nijmegen, The Netherlands.
  • Cormand B; Department of Cognitive Neuroscience, Donders Institute for Brain, Cognition and Behavior, Radboud University Medical Centre, Nijmegen, The Netherlands.
  • Crosbie J; Department of Genetics, Microbiology and Statistics, Faculty of Biology, University of Barcelona, Catalonia, Spain.
  • Faraone SV; Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Instituto de Salud Carlos III, Madrid, Spain.
  • Franke B; Institut de Biomedicina de la Universitat de Barcelona (IBUB), Barcelona, Catalonia, Spain.
  • Loo SK; Institut de Recerca Sant Joan de Déu (IR-SJD), Esplugues de Llobregat, Catalonia, Spain.
  • Miranda A; Psychiatry, Neurosciences and Mental Health, The Hospital for Sick Children, University of Toronto, Toronto, Canada.
  • Manor I; Departments of Psychiatry and Neuroscience and Physiology, SUNY Upstate Medical University, Syracuse, New York, USA.
  • Oades RD; Departments of Human Genetics and Psychiatry, Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Centre, Nijmegen, The Netherlands.
  • Purves KL; Department of Psychiatry and Biobehavioral Sciences, Semel Institute for Neuroscience and Human Behavior and David Geffen School of Medicine at UCLA, Los Angeles, CA, USA.
  • Ramos-Quiroga JA; Department of Developmental and Educational Psychology, University of Valencia, Valencia, Spain.
  • Ribasés M; Geha Mental Health Center, Petah Tikva, Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel.
  • Roeyers H; Department of Child and Adolescent Psychiatry and Psychotherapy, University of Duisburg-Essen, Essen, Germany.
  • Rothenberger A; Social, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.
  • Schachar R; Department of Psychiatry, Hospital Universitari Vall d'Hebron, Barcelona, Catalonia, Spain.
  • Sergeant J; Group of Psychiatry, Mental Health and Addictions, Vall d'Hebron Research Institute (VHIR), Barcelona, Catalonia, Spain.
  • Steinhausen HC; Biomedical Network Research Centre on Mental Health (CIBERSAM), Barcelona, Catalonia, Spain.
  • Vuijk PJ; Department of Psychiatry and Forensic Medicine, Universitat Autònoma de Barcelona, Barcelona, Catalonia, Spain.
  • Doyle AE; Department of Psychiatry, Hospital Universitari Vall d'Hebron, Barcelona, Catalonia, Spain.
  • Kuntsi J; Group of Psychiatry, Mental Health and Addictions, Vall d'Hebron Research Institute (VHIR), Barcelona, Catalonia, Spain.
Psychol Med ; 52(14): 3150-3158, 2022 10.
Article en En | MEDLINE | ID: mdl-33531098
ABSTRACT

BACKGROUND:

A recent genome-wide association study (GWAS) identified 12 independent loci significantly associated with attention-deficit/hyperactivity disorder (ADHD). Polygenic risk scores (PRS), derived from the GWAS, can be used to assess genetic overlap between ADHD and other traits. Using ADHD samples from several international sites, we derived PRS for ADHD from the recent GWAS to test whether genetic variants that contribute to ADHD also influence two cognitive functions that show strong association with ADHD attention regulation and response inhibition, captured by reaction time variability (RTV) and commission errors (CE).

METHODS:

The discovery GWAS included 19 099 ADHD cases and 34 194 control participants. The combined target sample included 845 people with ADHD (age 8-40 years). RTV and CE were available from reaction time and response inhibition tasks. ADHD PRS were calculated from the GWAS using a leave-one-study-out approach. Regression analyses were run to investigate whether ADHD PRS were associated with CE and RTV. Results across sites were combined via random effect meta-analyses.

RESULTS:

When combining the studies in meta-analyses, results were significant for RTV (R2 = 0.011, ß = 0.088, p = 0.02) but not for CE (R2 = 0.011, ß = 0.013, p = 0.732). No significant association was found between ADHD PRS and RTV or CE in any sample individually (p > 0.10).

CONCLUSIONS:

We detected a significant association between PRS for ADHD and RTV (but not CE) in individuals with ADHD, suggesting that common genetic risk variants for ADHD influence attention regulation.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Trastorno por Déficit de Atención con Hiperactividad / Disfunción Cognitiva Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Adolescent / Adult / Child / Humans Idioma: En Año: 2022 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Trastorno por Déficit de Atención con Hiperactividad / Disfunción Cognitiva Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Adolescent / Adult / Child / Humans Idioma: En Año: 2022 Tipo del documento: Article